semaglutide fatty liver Novo's trial of weight-loss drug shows improvement in disease Once-Weekly Subcutaneous Semaglutide Improves Fatty

In individuals who are deficient or those under high physical stress, such as athletes, the benefits can be even more pronounced

[DOI] [PubMed] [Google Scholar] 118.Stagnaro-Green A, Abalovich M, Alexander E, et al

In a Phase 2 study, 74% of patients taking Zepbound achieved an absence of non-alcoholic steatohepatitis (NASH) with no worsening of the liver fibrosis versus 12.6% for the placebo group

Restivo and Cecilia have been so helpful at the start of my weight loss journey

Positive Outcomes Beyond Glycemic Control: GLP-1 receptor agonists have been shown to have cardiovascular benefits, a significant consideration since T2D is a risk factor for heart disease